Recurrent head and neck cancer
Clinical trials for Recurrent head and neck cancer explained in plain language.
Never miss a new study
Get alerted when new Recurrent head and neck cancer trials appear
Sign up with your email to follow new studies for Recurrent head and neck cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can freezing tumors offer a new lifeline for head and neck cancer?
Disease control Recruiting nowThis pilot study is investigating whether local cryotherapy—a procedure that freezes and destroys cancer cells—can control recurrent head and neck cancer in patients who have already received radiation therapy and cannot undergo surgery or further radiation. The trial will enroll…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New triple-drug cocktail takes on hard-to-treat head and neck cancer
Disease control Recruiting nowThis phase 2 trial is testing a combination of three therapies—modified immune cells (PD-L1 t-haNK), an immune-boosting protein (NAI/Anktiva), and a targeted antibody (cetuximab)—in 25 people with recurrent or metastatic head and neck cancer that has not responded to prior immuno…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Ultrasound boosts cancer drug in tiny trial
Disease control Recruiting nowThis early study tests whether using ultrasound and microbubbles can help the immunotherapy drug pembrolizumab (Keytruda) work better in people with head and neck cancer that has come back or spread. Only 6 participants will receive three rounds of treatment. The main goal is to …
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase 1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC